December 05, 2025

3 things you missed in government this week

ADA News is providing a roundup of government happenings you may have missed this week.

ADA News

December 03, 2025

Medical Oddities: Is Glute Shape the New Vital Sign?

From backside biology to radon residues, plant diets to memory quirks—we’re covering it all.

Conexiant

November 24, 2025

Oral PCSK9 Inhibitor Tied to LDL-C Drop

The oral PCSK9 inhibitor enlicitide decanoate achieved 58% LDL-C reduction in patients with heterozygous familial hypercholesterolemia, offering a potential alternative to injectable therapies.

Conexiant

November 21, 2025

ALD-related HCC mortality surges 

 The findings underscore the urgent need for targeted prevention strategies among high-risk group.

Conexiant

November 21, 2025

Tirzepatide tops semaglutide for cardiometabolic protection in MASLD

The study authors recommend prospective head-to-head trials to validate the findings.

Conexiant

November 20, 2025

New score challenges old predictors

"MERAGE has superior performance for predicting return to drinking (RTD) compared to HRAR in AH."

Conexiant

November 18, 2025

Roswell Park at ASH 2025

Roswell Park invites you to come meet some of our nationally recognized experts in transplant and cellular therapy and hematologic malignancies at this year’s ASH conference in Orlando, taking place December 6-9, 2025. 

Roswell Park Comprehensive Cancer Center

November 15, 2025

NGS Streamlines Clonal Detection in Plasma Cells

Research presented at AMP 2025 shows high-sensitivity sequencing may eliminate CD138 selection and speed identification of high-risk patients.

Conexiant

November 15, 2025

Optimizing Diagnostic Stewardship: The Clinician’s Perspective

Recommendations focus on reducing unnecessary testing and treatment while improving diagnostic accuracy.

Conexiant